Members of the team that developed MSK-ACCESS. From left to right: Michael Berger, Marc Ladanyi, Dana Tsui, Rose Brannon, Ryma Benayed, Ahmet Zehir, and David Klimstra. Photo from February 2020. One ...
CAR T cell therapy, often referred to as a “living drug,” has successfully treated blood cancers such as leukemia and lymphoma. The approach, which was pioneered at Memorial Sloan Kettering Cancer ...
NEW YORK, May 18, 2022 – New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a ...
BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq: SOPH), a pioneer in AI healthcare technology and a leader in data-driven medicine, announced a new milestone ...
Oncologists explain scenarios for which they may retest patients previously assessed via genomic profiling. Bruce Feinberg, DO: Mark, what’s your delay? First, the way the it works at Memorial [Sloan ...
New findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) and published today in the journal Nature Communications report the results of using a comprehensive sequencing approach ...
Doctors at Memorial Sloan Kettering Cancer Center (MSK) pioneered advances in a variety of cancer treatment for patients in 2023. The results from many cutting-edge clinical trials this year are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback